Type 2 diabetes tied to raised risk of tumors, cancer deaths

October 3, 2018

(HealthDay)—Type 2 diabetes is associated with an increased risk of developing cancer and dying from certain forms of the disease, a new study suggests.

However, the researchers noted, the absolute increased risk is low.

"Our findings do not suggest that everyone who has diabetes will go on to develop in later life," said study leader Hulda Hrund Bjornsdottir, from the Swedish National Diabetes Register.

Her team analyzed data gathered between 1998 and 2014 from more than 450,000 people in Sweden with type 2 diabetes and more than 2 million people without diabetes who were followed for an average of seven years. The study focused on 12 types of cancer.

The study couldn't prove cause-and-effect. However, compared to those without type 2 diabetes, people with the blood sugar disease had a 231 percent higher risk of liver cancer, a 119 percent higher risk of and a 78 percent higher risk of uterine cancer.

In addition, those with diabetes had an increased risk of penile cancer (56 percent higher), kidney cancer (45 percent higher), gallbladder and (32 percent higher), and stomach cancer (21 percent higher). They also had a 20 percent higher risk of colorectal cancer and bladder cancer, and a 5 percent higher risk of breast cancer.

The research was to be presented Tuesday at the annual meeting of the European Association for the Study of Diabetes, in Berlin.

The findings don't necessarily mean that diabetes somehow causes cancer, Bjornsdottir stressed. Instead, "diabetes and cancer share certain risk factors that might contribute to these associations, including obesity, smoking and diet," she explained in a meeting news release.

When the investigators looked at the results over a 10-year period, they found there was a 38 percent greater increase in new cases of pancreatic cancer and a 30 percent greater increase in lung cancer incidence among people with type 2 diabetes than among those without the .

The researchers also found that among patients with type 2 diabetes, death rates were 29 percent higher for prostate cancer, 25 percent higher for breast cancer and 9 percent higher for colon cancer, when compared with people without diabetes.

"With the number of people with type 2 diabetes doubling over the past 30 years, our findings underscore the importance of improving ," Bjornsdottir said.

Now, with diabetes tied to cancer , "the importance of a healthy lifestyle is clearer than ever," she added.

More than 415 million people worldwide have —about one in 11 adults—and the number is expected to rise to 642 million by 2040, the study authors noted.

Research presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.

Explore further: Cancer development linked to increased diabetes risk

More information: The American Academy of Family Physicians has more on diabetes.

Related Stories

Cancer development linked to increased diabetes risk

June 11, 2018
(HealthDay)—Cancer development is associated with increased risk of subsequent type 2 diabetes mellitus, according to a study published online June 7 in JAMA Oncology.

Diabetes may be an early manifestation of pancreatic cancer

June 18, 2018
A new study in the Journal of the National Cancer Institute, published by Oxford University Press, indicates that recent-onset type 2 diabetes may be early expression of pancreatic cancer. Diabetes was associated with a more ...

Diabetes, dementia can be deadly combination

October 2, 2018
(HealthDay)—The risk of death from dangerously low blood sugar is much higher among seniors who have both diabetes and dementia than those with diabetes alone, a new study finds.

Diabetes impacts mortality in breast cancer patients

January 26, 2018
(HealthDay)—Breast cancer-specific mortality remains higher among women with diabetes who have longer diabetes duration or preexisting cardiovascular disease, according to a study published online Jan. 19 in Diabetes Care.

Cancer risk may rise before and immediately after a diabetes diagnosis

July 11, 2016
A new study indicates that individuals with diabetes may have an elevated risk of developing cancer before and immediately after a diabetes diagnosis. Published early online in Cancer, a peer-reviewed journal of the American ...

Type 2 diabetes associated with risk of aggressive breast cancer in black women

November 15, 2017
African American women with type 2 diabetes (often referred to as adult-onset diabetes) are at a greater risk for developing breast cancer.

Recommended for you

Treatment shown to improve the odds against bone marrow cancer

December 15, 2018
Hope has emerged for patients with a serious type of bone marrow cancer as new research into a therapeutic drug has revealed improved outcomes and survival rates.

Does diabetes damage brain health?

December 14, 2018
(HealthDay)—Diabetes has been tied to a number of complications such as kidney disease, but new research has found that older people with type 2 diabetes can also have more difficulties with thinking and memory.

Researchers study abnormal blood glucose levels of discharged patients

December 14, 2018
University of Minnesota Medical School researchers decided to delve into an area where little data currently exists. They wanted to know what happens after these patients with abnormal blood glucose measurements are discharged? ...

Researchers zero in on potential therapeutic target for diabetes, associated diseases

December 14, 2018
A recent study led by researchers in Texas A&M University's department of nutrition and food science shows how a novel regulatory mechanism serves as an important biomarker for the development of diabetes, as well as a potential ...

Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

December 14, 2018
People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England.

New drug seeks receptors in sarcoma cells, attacks tumors in animal trials

December 13, 2018
A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.